Furthermore, a recent study demonstrated the development of a chimeric antigen receptor (CAR) against STEAP1, which showed remarkable efficacy against prostate cancer cells both in vitro and in vivo (7). This evidence concerns the gene STEAP1 and Familial prostate cancer.